While the initial surgery shows promise, significant uncertainties remain about long-term outcomes and rejection risks. The procedure requires lifelong immunosuppression medication, limiting eligible candidates to those already on transplant medications or requiring multiple organ transplants. The true success of this pioneering surgery can only be determined after extensive clinical trials and long-term monitoring.